Effect of carbohydrate restriction and American Heart Association diets on the clinical features of the metabolic syndrome, the inflammatory response and lipoprotein metabolism in young Emirati adults
by Al-Sarraj, Taif S., Ph.D., UNIVERSITY OF CONNECTICUT, 2009, 204 pages; 3360684

Abstract:

The incidence of diabetes mellitus (DM) in the UAE is one of the highest world-wide. The metabolic syndrome (MetS) characterized by central obesity, high blood pressure and dyslipidemias predisposes for the development of DM. The presence of MetS was assessed in a population of overweight/obese individuals by randomly screening 227 subjects, 18-50 (30.2 ± 8.4 y), from Al-Ain city, Emirate of Abu Dhabi. 92 subjects (40.5%) were identified as having MetS. The most relevant clinical criteria associated with MetS were large waist circumference (WC), high systolic blood pressure and low HDL cholesterol (HDL-C).

Dietary interventions were conducted in 39 subjects. Initially, all individuals followed a carbohydrate restricted diet (CRD) with 25% energy from carbohydrate. After 6 wk, half of the subjects (n=19) were switched to the low fat diet (55% energy from carbohydrate) recommended by the American Heart Association (AHA group) while the other half (n=20) continued with the CRD diet for additional 6 wk (CRD group). Diet records indicated high compliance with the dietary guidelines. At wk 6, all subjects presented decreases in body weight (P < 0.0001), WC (P < 0.001), body fat (P < 0.0001) and plasma triglycerides (TG) (P < 0.0001). Significant decreases were also seen in plasma LDL cholesterol, blood pressure, insulin and inflammation markers while a significant increase in adiponectin was observed. After 12 wk, these positive changes persisted for all subjects independent of diet. However, body weight, plasma TG, insulin and plasma glucose were lower in the CRD (P < 0.05) compared to the AHA group.

The large atherogenic VLDL subfraction was decreased over time for all subjects (P < 0.01) with a more pronounced decrease (P <0.05) in the CRD compared to the AHA group. Medium and small LDL particles and apolipoprotein B decreased for all subjects (P < 0.01) rendering a less atherogenic lipoprotein profile. These studies indicate that CRD can effectively be used as a dietary intervention to decrease the biomarkers of the MetS and to reduce the number of atherogenic particles in plasma in young Emirati. Further, CRD was a better option to maintain low plasma TG and glucose and to improve insulin sensitivity compared to the AHA diet.

 
Advisor
SchoolUNIVERSITY OF CONNECTICUT
SourceDAI/B 70-05, p. , Aug 2009
Source TypeDissertation
SubjectsNutrition; Public health; Physiology
Publication Number3360684
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3360684
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.